6680
A. R. Suresh Babu et al. / Tetrahedron Letters 53 (2012) 6676–6681
Sons: New York, 2002; p 169.; (c) Gothelf, K. V. Cycloaddition Reactions in
O
O
O
Organic Synthesis; Kobaya-shi, S., Jorgensen, K. A., Eds.; Wiley-VCH: Weinheim,
Germany, 2002; Chapter 6, p 211.; (e) Shanmugam, P.; Viswambharan, B.;
Madhavan, S. Org. Lett. 2007, 9, 4095.
H
NH2
NH2
OH
OH
COOH
N
H
11. SureshBabu, A. R.; Raghunathan, R. Tetrahedron Lett. 2008, 49, 4487.
12. Suresh Babu, A. R.; Raghunathan, R. Tetrahedron Lett. 2009, 50, 2818.
13. Suresh Babu, A. R.; Raghunathan, R. Synth. Commun. 2009, 39, 2889.
14. Suresh Babu, A. R.; Raghunathan, R. Synth. Commun. 2010, 40, 2311.
15. (a) Posner, G. H. Chem. Rev. 1986, 86, 23; (b) Azizian, J.; Mohammaddizadeh, M.
R.; Karimi, N.; Kazemizadeh, Z.; Mohammadi, A. A.; Karimi, A. Heteroat. Chem.
2005, 16, 549; (c) Son, J. K.; Park, J. G.; Jahng, Y. D. Heterocycl. Commun. 2003, 9,
621; (d) Azizian, J.; Mohammaddizadeh, M. R.; Zomorodbakhsh, S.;
Mohammadi, A. A.; Karimi, A. R. Arkivoc 2007, 1, 24.
O
Fe
4
3
16
2
MeOH
Reflux
16. (a) Broggini, G.; Zecchi, G. Synthesis 1999, 905; (b) Najera, C.; Sansano, J. M.
Angew. Chem., Int. Ed. 2005, 44, 6272; (c) Azizian, J.; Karimi, A. R.; Kazemizadeh,
Z.; Mohammadi, A. A.; Mohammaddizadeh, M. R. Tetrahedron Lett. 2005, 46,
6155; (d) Azizian, J.; Karimi, A. R.; Kazemizadeh, Z.; Mohammadi, A. A.;
Mohammaddizadeh, M. R. Synthesis 2004, 14, 2263; (e) Suresh Babu, A. R.;
Raghunathan, R. Synth. Commun. 2009, 39, 347.
17. (a) Allway, P.; Grigg, R. Tetrahedron Lett. 1991, 32, 5817; (b) Coulter, T.; Grigg,
R.; Malone, J. F.; Sridharan, V. Tetrahedron Lett. 1991, 32, 5417; (c) Grigg, R.;
Idle, J.; Mc Meekin, M.; Surendrakumar, S.; Vinod, D. J. Chem. Soc., Perkin Trans.
1 1988, 2693.; (d) Grigg, R.; Idle, J.; Mc Meekin, M.; Surendrakumar, S.; Vinod,
D. J. Chem. Soc., Perkin Trans. 1 1988, 2703.
O
Fe
H
O
H
H
O
N
H
N
N
Fe
O
N
N
18. (a) A complete data of our report on the crystal structure of two analogs in
N
ferrocene appended spiro-oxindolopyrrolizidine namely Spiro-[2.30]-50,70-
18
Spiro-[2.30]-
17
dibromooxindole-3-ferrocenoyl-4-furyl-pyrrolizidine
and
oxindole-3-(p-methoxybenzoyl)-4-ferrocenyl-pyrrolizidine can be obtained
from the Cambridge Crystallographic Data Centre with the deposition
Scheme 5. Synthesis of ferrocene grafted dispiro-indenoquinoxaline indane-1,3-
dione pyrrolizidine 17.
number
CCDC
6756597
and
CCDC
29236.
Data
acquisition:
Babu, A. R.; Raghunathan, R. Synth. Commun. 2008, 38, 1433; (c) Suresh Babu,
A. R.; Raghunathan, R. Synth. Commun. 2009, 39, 347.
19. (a) Vilemin, D.; Martin, B.; Puciova, M.; Toma, S. J. Organomet. Chem. 1994, 484,
27; (b) Ji, S. J.; Shen, Z. L.; Wang, S. Y. Chin. Chem. Lett. 2003, 14, 663; (c)
Mendez, D. I.; Klimova, E.; Klimova, T.; Fernando, L.; Hernandez, S. O.; Marinez,
M. G. J. Organomet. Chem. 2003, 679, 10; (d) Stankovic, E.; Elecko, P.; Toma, S.
Chem. Pap. 1996, 50, 68.
20. Gayathri, D.; Aravindan, P. G.; Velmurugan, D.; Ravikumar, K.; Suresh Babu, A.
R. Acta Cryst. 2005, E61, o3124.
21. General procedure for the synthesis of ferrocene based spiro-indenoquinoxaline
pyrrolizidines: A mixture of ninhydrin 2 (1 mmol) and 1,2-phenylenediamine 3
(1 mmol) was stirred for 10 min in 10 mL of methanol followed by the addition
pattern by choice. This method offers several advantages including
its simplicity with a one-pot four-component approach, mild reac-
tion conditions, easy workup, affording the desired products from
readily and cheaply available starting materials in a single step.
This method is general and is applicable to a variety of unusual
ferrocene derived dipolarophiles to synthesize such complex
highly substituted pyrrolizidines containing ferrocene and spiro-
indenoquinoxaline moiety of biological significance.
of L-proline 4 (1 mmol). To this mixture, a solution of dipolarophile 1a
(1 mmol) in 10 ml of methanol was added. The mixture was then refluxed until
completion of the reaction as evidenced by TLC. The solvent was removed
under reduced pressure and the crude product obtained was purified by
column chromatography using petroleum ether/ethyl acetate (4:1) as eluent.
Alternatively, the reaction could also be carried out in toluene using a Dean-
Acknowledgments
A.R.S. thanks CEFIPRA (le Centre Indo - Français Pour la Recherche
Avancée) for the nomination under postdoctoral programme-2012.
R.R. thanks DST and DST-FIST, New Delhi, for financial support.
Stark
apparatus.
Spiro-[2.110]-indeno[1,2-b]quinoxaline-3-ferrocenoyl-4-(p-
methoxylphenyl)- pyrrolizidine 5a: 1H NMR (300 MHz, CDCl3): d 1.72–1.98 (m,
2H), 2.00–2.22 (m, 2H), 2.43–2.46 (m, 1H), 2.72–2.78 (m, 1H), 3.25 (t, J = 1.2 Hz,
1H), 3.44 (s, 5H), 3.60 (d, 0J = 1.2.Hz 1H), 3.68 (s, 3H, –OMe), 3.99–4.01 (m, 1H),
4.10 (t, J = 10.5 Hz, 1H, H1 ), 4.30–4.31 (t, J = 1.2 Hz, 1H), 4.53 (dt, J = 9.9, 6.3 Hz,
References and notes
0
0
1H, H7 a), 4.67 (d, J = 11.1 Hz, 1H, H2 ), 6.87–6.90 (m, 2H), 7.30–7.42 (m, 2H),
7.56–7.72 (m, 5H), 7.89–7.92 (m, 1H), 7.99–8.02 (m, 1H), 8.30–8.32 (m, 1H);
13C NMR (75 MHz, CDCl3): d 24.76, 27.71, 45.68, 49.76, 52.92, 64.97, 65.97,
66.44, 66.77, 69.15, 69.72, 72.54, 74.16, 76.55, 111.82, 119.62, 126.15, 126.32,
122.63, 127.01, 127.04, 127.14, 127.42, 128.38, 130.58, 134.95, 139.68, 140.39,
141.56, 150.60, 156.58, 163.03, 197.81 ppm; EIMS m/z: 631(M+); CHN analysis
Calcd for C39H33N3O2Fe: C, 74.17; H, 5.27; N, 4.21%. Found: C, 74.36; H, 5.35; N,
4.29%. Spiro-[2.110]-indeno[1,2-b]quinoxaline-3-ferrocenoyl-4-furyl-pyrrolizidine
11a: 1H NMR (300 MHz, CDCl3): d 1.80–2.20 (m, 4H), 2.48–2.52 (m, 1H),
2.68–2.72 (m, 1H), 3.40 (s, IH), 3.71 (s, 5H), 4.04 (s, 1H), 4.10 (s, 1H), 4.37 (t,
1. Schreiber, S. L. Science 2000, 287, 1964.
2. Terrett, N. K. Combinatorial Chemistry; Oxford University Press: New York,
1998.
3. For reviews, see: (a) Bienayme, H.; Hulme, C.; Oddon, G.; Schmitt, P. Chem. Eur.
J. 2000, 6, 3321; (b) Ugi, J.; Heck, S. Comb. Chem. High Throughput Screening
2001, 4, 10; (c) Nair, V.; Rajesh, C.; Vinod, A. U.; Bindu, S.; Sreekanth, A. R.;
Mathen, J. S.; Balagopala, L. Acc. Chem. Res. 2003, 36, 899.
4. (a) Weber, L. Drug Discovery Today 2002, 7, 143; (b) Domling, A. Curr. Opin.
Chem. Biol. 2002, 6, 306.
5. Shi, F.; Mancuso, R.; Larock, R. C. Tetrahedron Lett. 2009, 50, 4067.
6. Pearson, W. H. Studies in Natural Product Chemistry; Rahman, A. U., Ed.; Elsevier:
Amsterdam, 1998; Vol. 1, p 323.
7. (a) Hartmann, T.; Witte, L. Chemistry, Biology and Chemoecology of
Pyrrolizidine Alkaloids In Alkaloids: Chemical and Biological Perspectives;
Pelletier, S. W., Ed.; Pergamon Press: Oxford, UK, 1995; Vol. 9, p 323; (b)
Monlineux, R. J. In Alkaloids: Chemical and Biological Perspective; Pelletier, S. W.,
Ed.; Wiley: New York, 1987. Chapter 1.
0
0
J = 10.8 Hz, 1H, H1 ), 4.40 (s, 1H), 4.62–4.66 (m, 1H, H7 a), 4.90 (d, J = 11.4 Hz,
0
1H, H2 ), 6.37–6.43 (m, 2H), 7.41–8.38 (m, 9H); 13C NMR (75 MHz, CDCl3): d
27.33, 29.68, 30.53, 46.06, 47.91, 63.96, 68.42, 69.47, 71.71, 72.37, 75.08, 78.84,
106.95, 110.65, 122.11, 128.43, 128.82, 129.56, 130.82, 137.34, 141.58, 142.10,
142.79, 143.71, 153.06, 153.77,164.91, 199.59 ppm; EIMS m/z: 591 (M+); CHN
analysis Calcd for C36H29N3O2Fe: C, 73.10; H, 4.94; N, 7.10%. Found: C, 72.93; H,
5.07; N, 7.22. Spiro-[2.110]-indeno[1,2-b]quinoxaline-3-ferrocenoyl-4-pyridyl-
pyrrolizidine 13: 1H NMR (300 MHz, CDCl3): d 1.80–2.03 (m, 4H), 2.43–2.45
8. (a) Gazit, A.; App, H.; Mc Mahon, G.; Chen, J.; Levitzki, A.; Bohmer, F. D. J. Med.
Chem. 1996, 39, 2170; (b) Sehlstedt, U.; Aich, P.; Bergman, J.; Vallberg, E. I.;
Norden, B.; Graslund, A. J. Mol. Biol. 1998, 278, 3156; (c) Trillo, R. P.; Univ.
Microfilms (Ann. Arbor. Mich.), L.C. card no. Mic. 59–4672, 106, Dissertation
Abstr. 1959, 20, 1597.; (d) Igor, A. S.; Liliya, N. K.; Andrei, I. K.; Tracey, S. H.;
Irina, K.; David, W. P.; Mark, A. J.; Mark, T. Q. Mol. Pharmacol. 2012, 81, 832.
9. (a) Ruck-Braun, K.; Freysoldt, T. H. E.; Wierschem, F. Chem. Soc. Rev. 2005, 34,
507; (b) Pandey, G.; Banerjee, P.; Gadre, S. R. Chem. Rev. 2006, 106, 4484; (c)
SureshBabu, A. R.; Raghunathan, R.; Madhivanan, R.; Ompraba, G.; Velmurugan,
D.; Raghu, R. Curr. Chem. Biol. 2008, 2, 312; (d) Babu, A. R. S.; Raghunathan, R.;
Kumaresan, K.; Raaman, N. Curr. Chem. Biol. 2009, 3, 432.
(m, 1H), 2.78–2.80 (m, 1H), 3.18 (s, IH), 3.45 (s, 5H), 3.63 (s, 1H), 4.03 (d,
0
J = 2.1 Hz, 1H), 4.13 (t, J = 10.2 Hz, 1H, H10 ), 4.32 (d, J = 1.2 Hz, 1H), 4.52–4.58
0
(m, 1H, H7 a), 4.68 (d, J = 10.8 Hz, 1H, H2 ), 7.32–7.51 (m, 2H), 7.66–7.72 (m,
2H), 7.90–8.04 (m, 4H), 8.28–8.56 (m, 2H); 13C NMR (75 MHz, CDCl3): d 26.93,
29.74, 47.99, 52.08, 60.36, 67.08, 68.97, 69.51, 71.80, 72.66, 74.67, 75.84,
122.17, 124.05, 128.34, 129.13, 129.70, 130.93, 137.46, 141.97, 142.83, 143.43,
146.15, 149.15, 150.09, 150.77, 153.03, 165.16, 200.34 ppm; EIMS m/z: 605
(M+); CHN analysis Calcd for C37H30N4OFe: C, 73.75; H, 5.02; N, 9.29%. Found:
C, 73.88; H, 5.20; N, 9.45%. Spiro-[2.110]-indeno[1,2-b]quinoxaline-3-ferrocenoyl-
4-ferrocenyl pyrrolizidine 15: 1H NMR (300 MHz, CDCl3): d 1.88–2.20 (m, 4H),
2.28–2.68 (m, 2H), 3.29 (s, 1H), 3.54 (s, 2H), 3.57 (s, 1H), 3.66 (s, 5H), 4.08 (t,
0
10. (a) Najera, C.; Sansano, J. M. Curr. Org. Chem. 2003, 7, 1105; (b) Harwood, L. M.;
Vickers, R. J. Synthetic Applications of 1,3-Dipolar Cycloaddition Chemistry Toward
Heterocycles and Natural Products; Padwa, A., Pearson, W. H., Eds.; John Wiley &
J =011 Hz, IH, H1 ), 4.21 (s, 2H), 4.25 (s, 2H), 4.27 (s, 5H), 4.52 (d, J = 11.0 Hz, 1H,
0
H7 a), 4.88 (d, J = 11.1 Hz, 1H, H2 ), 7.34–8.26 (m, 8H, ArH); 13C NMR (75 MHz,
CDCl3): d 27.38, 28.68, 31.95, 44.27, 46.03, 64.89, 66.38, 67.67, 67.96, 68.40,